More interestingly, the percentage of Vδ1−Vδ2− γδ T cells was significantly higher in IFN-β-treated MS patients than in untreated MS and HCs (padj = 0.002 and padj < 0.001, respectively). Here, IFNB1 is linked to myeloid sarcoma.